<DOC>
	<DOCNO>NCT01316419</DOCNO>
	<brief_summary>This observational study design evaluate effect Twynsta tablets life style modification blood pressure , quality life , risk factor Korean patient hypertension routine clinical practice setting .</brief_summary>
	<brief_title>Twynsta Study With Lifestyle Modifications Korean Patients With Hypertension</brief_title>
	<detailed_description>Study Design :</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Inclusion criterion : 1 . Patients essential hypertension whose blood pressure adequately control amlodipine telmisartan monotherapy ( =140/90 mmHg , = 130/80 mmHg diabetes kidney disease ) 2 . Age = 19 year enrollment 3 . Male female patient ( legally acceptable representative ) willing able provide write informed consent Exclusion criterion : 1 . Patients previous exposure Twynsta 2 . Patients hypersensitivity active substance , dihydropyridine derivative 3 . Female patient second third trimester pregnancy 4 . Female patient lactation 5 . Patients biliary obstructive disorder 6 . Patients severe hepatic impairment 7 . Patients high grade aortic stenosis 8 . Patients shock 9 . Patients hereditary condition intolerance excipient product 10 . Current participation clinical trial observational study</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>